Impact of programmed cell death protein 1 inhibitor therapy on the survival of patients with advanced or recurrent uterine cancers: a meta-analysis

Overview of attention for article published in Frontiers in immunology, March 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 2 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 33,342 followers.

New Research: Impact of programmed cell death protein 1 inhibitor therapy on the survival of patients with advanced or recurrent uterine cancers: a meta-analysis: Introduction No prior meta-analysis has investigated the impact of programmed… https://t.co/

18 Mar 2024

Reply Repost Favourite

Impact of programmed cell death protein 1 inhibitor therapy on the survival of patients with advanced or recurrent uterine cancers: a meta-analysis https://t.co/wAI2Vk4LCP #FrontImmunol

18 Mar 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.